Signal Genetics Inc

-

Assets, Funds, Holdings

Home | Sign Up | Log In
New Features
Latest Fund Raises
Related People
Fund Service Providers
Startup & Company Raises
List of Funds
Boston Firms
Boston Hedge Funds
Cornell Alumni Firms
CalPERS Portfolio
NYSCRF Portfolio
User Guide
Regulatory AUM vs AUM
LP Portfolios
Related Firms
Build a Portfolio
Comprehensive Search
Keyboard
Signal Genetics Inc
CIK #0001590750
EDGAR Form CIK 2011 - 2026
10-K [0001590750]
10-Q [0001590750]
3 [0001590750]
4 [0001590750]
5 [0001590750]
8-K [0001590750]
D [0001590750]
SC 13D [0001590750]
SC 13G [0001590750]
Form 13D/13G Filer Form 13D/13G Subject Filed
Paradigm Biocapital Advisors LP Viridian Therapeutics Inc de [2026-06-26]
Bellevue Group AG Viridian Therapeutics Inc de [2026-05-15]
Deep Track Capital LP Viridian Therapeutics Inc de [2026-05-08]
Kynam Capital Management LP Viridian Therapeutics Inc de [2025-05-15]
Commodore Capital LP Viridian Therapeutics Inc de [2025-04-11]
Perceptive Advisors LLC Viridian Therapeutics Inc de [2024-01-29]
State Street Corp Viridian Therapeutics Inc de [2024-01-24]
FMR LLC Viridian Therapeutics Inc de [2024-01-10]
Venrock Opportunities Fund LP Viridian Therapeutics Inc de [2023-12-08]
Paradigm Biocapital Advisors LP Viridian Therapeutics Inc de [2023-05-11]
View All
Form 3/4/5 Subject 2011 - 2026
Miragen Therapeutics Inc
Cain Christopher W
Morris Arlene
Gheuens Sarah
Kiselak Tomas
Ajer Jeffrey Robert
Moses Jennifer K
Fairmount Healthcare Fund II GP LLC
Fairmount Healthcare Fund II LP
Fairmount Funds Management LLC
Tripuraneni Radhika
Beetham Thomas W
Mahoney Stephen F
Tousignant Jennifer
Harmon Seth
Harwin Peter Evan
Fairmount Healthcare Fund GP LLC
Fairmount Healthcare Fund LP
Ciulla Thomas
Meisner Lara
Myers Scott Dunseth
Katz Barrett
Melvin Carrie
Humer Kristian
Violin Jonathan
Fhmlsp LLC
Frazier Life Sciences Public Fund LP
Fhmlsp LP
Turner Joseph L
Hatfield Jeffrey S
Leverone Jason A
Escolar Diana
Rauch Lee M
Marshall William Stuart
Shah Rajeev M
RA Capital Healthcare Fund LP
RA Capital Management LP
Kolchinsky Peter
Point72 Asset Management LP
Cohen Steven A/SAC Capital Mgmt LP
Point72 Capital Advisors Inc
Logos Global Master Fund LP
Bowden Christopher
Koch Kevin
Hughes Thomas E
Rubin Paul D
Levy Adam Scott
Booth Bruce
Lefkoff Kyle
Creecy John W
Remeditex Ventures LLC
Atlas Venture Fund VII L P
Lebow Bennett S
Gonyer David A
Smith Robin L
Riccitelli Samuel D
Favorito Tamara A
Schuling Douglas A
Johnson Robert Brian
Lebow Alpha LLLP
Insider Transaction (Form 3/4/5) Date Action Shares Price Value ($)
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 5,169
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 6,267 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 9,409
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 9,409 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 3,138 $29.32 92,006
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 1,724 $29.32 50,548
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 7,627 $29.32 223,624
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 18,357
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 18,357 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Option exercise 6,267
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-03 Option exercise 5,169 $0.00
Miragen Therapeutics Inc VRDN
Common Stock
2026-03-03 Tax withheld 2,091 $29.32 61,308
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 176,550 $0.00
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 119,300 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 23,850 $0.00
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 102,850 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 20,550 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 35,300 $0.00
Miragen Therapeutics Inc VRDN
Restricted Stock Units · derivative
2026-03-02 Grant 111,900 $0.00
Miragen Therapeutics Inc VRDN
Stock Option (Right to Buy) · derivative
2026-03-02 Grant 559,600 $0.00
showing 20 of 200 most recent transactions
Terms | Privacy | Providers | Companies | Guide
tony@aum13f.com